Benzodiazepines are not opioids. They belong to an entirely separate class of drugs, work through different brain receptors, and produce their effects by distinct mechanisms. The confusion is understandable: both are prescription medications that can cause sedation, both carry risks of dependence, and both are frequently mentioned in the same breath during discussions of overdose deaths. But pharmacologically, a benzodiazepine like Xanax or Valium has about as much in common with an opioid like oxycodone or fentanyl as a sleeping pill has with a painkiller, which is essentially what they are.
How Benzodiazepines Work
Benzodiazepines target GABA-A receptors, the brain’s main “slow down” switches. GABA is a chemical messenger that dampens nerve activity, and when a benzodiazepine binds to a GABA-A receptor, it amplifies the calming signal that GABA is already sending.1PubMed Central. Benzodiazepine Modulation of GABAA Receptors: A Mechanistic Perspective The result is reduced anxiety, muscle relaxation, sedation, and in higher doses, sleep or even amnesia. Common benzodiazepines include diazepam (Valium), alprazolam (Xanax), lorazepam (Ativan), and clonazepam (Klonopin). Doctors prescribe them for anxiety disorders, panic attacks, seizures, insomnia, and sometimes alcohol withdrawal.
The key detail is that benzodiazepines do not create a calming signal on their own. They make the brain’s existing calming signal louder. Without GABA already present at the receptor, a benzodiazepine does very little. This is part of why benzodiazepines alone, while dangerous in overdose, are less immediately lethal than opioids taken alone in equivalent excess.
How Opioids Work
Opioids act on an entirely different set of receptors, called mu, kappa, and delta opioid receptors, which are scattered throughout the brain, spinal cord, and gut. When an opioid binds to these receptors, it directly blocks pain signals and triggers a release of dopamine that produces intense feelings of well-being or euphoria. Unlike benzodiazepines, opioids do not need an existing signal to amplify. They activate the receptor directly, which is one reason opioid overdoses can so rapidly shut down breathing.
Opioids include prescription painkillers like oxycodone, hydrocodone, and morphine, as well as illicit drugs like heroin and illegally manufactured fentanyl. They are prescribed primarily for pain management, though some (like codeine) also suppress coughs. The respiratory depression they cause, meaning a dangerous slowing of breathing, is the primary way opioid overdoses kill.
Why People Confuse the Two
Several things feed this misunderstanding. Both drugs are central nervous system depressants, meaning they slow brain activity. Both can make you drowsy, impair coordination, and cloud your thinking. Both carry warnings about dependence. And both show up routinely in overdose statistics and news coverage, often in the same sentence.
Research has shown that lumping depressant substances together leads to a loss of vital information, particularly when trying to understand patterns of misuse.2PubMed. Examining the link between nonmedical use of sedatives, tranquilizers, and pain relievers with dispositions toward impulsivity among college students In other words, treating “downers” as one category obscures the very real differences in how these drugs behave, who uses them, and what the risks look like. When public health messaging or media coverage treats benzodiazepines and opioids as interchangeable dangers, the nuances that could save lives get lost.
Another source of confusion is the controlled substance scheduling system. In the United States, most benzodiazepines are Schedule IV controlled substances, while most prescription opioids are Schedule II. Both schedules signal that the government considers these drugs to have some potential for misuse and dependence, which can make them seem more alike than they are. The scheduling reflects abuse risk and medical usefulness, not pharmacological similarity.
The Danger of Combining Them
If benzodiazepines and opioids were truly the same thing, combining them would just be “taking more of the same.” In reality, combining them is far more dangerous than doubling the dose of either one alone, precisely because they suppress the body through different pathways. Opioids directly slow the brainstem’s respiratory drive. Benzodiazepines dampen overall brain excitability through GABA. When both systems are suppressed simultaneously, the effect on breathing is more than additive. Patients on both drug classes face a higher risk of fatal and nonfatal overdose, along with more problematic drug-use patterns.3PubMed Central. Opioid deaths involving concurrent benzodiazepine use: assessing risk factors through the analysis of prescription drug monitoring data and postmortem toxicology
The numbers bear this out. Between 1999 and 2017, benzodiazepine involvement in opioid overdose deaths rose from under 9% to 21%. By 2017, benzodiazepines were present in about a third of prescription opioid overdose deaths and roughly 17% of deaths involving synthetic opioids like fentanyl.4JAMA Network Open. Alcohol or Benzodiazepine Co-involvement With Opioid Overdose Deaths in the United States, 1999-2017 One study found that a filled prescription for alprazolam was the single best drug predictor of a subsequent opioid-related death among people with prescription histories.3PubMed Central. Opioid deaths involving concurrent benzodiazepine use: assessing risk factors through the analysis of prescription drug monitoring data and postmortem toxicology That finding does not mean alprazolam caused those deaths. It means that people who had both types of prescriptions active were at substantially greater risk.
This combination risk prompted the FDA to add a boxed warning to both opioid and benzodiazepine prescriptions in 2016. Following that warning, coprescribing dropped by about 18% over the next year and a half, translating to roughly 316,000 fewer patients receiving both drugs simultaneously.5JAMA Psychiatry. Opioid and Benzodiazepine Coprescribing in the United States Before and After US Food and Drug Administration Boxed Warning Before that warning, about 67 million patients in the U.S. were filling either an opioid or benzodiazepine prescription in a given year, so the overlap was substantial.
Dependence and Withdrawal Look Very Different
Both benzodiazepines and opioids can produce physical dependence, meaning your body adapts to the drug’s presence and reacts when the drug is removed. But the mechanisms of dependence and the nature of withdrawal are strikingly different, and understanding those differences matters if you or someone you know is trying to stop either drug.
With benzodiazepines, tolerance develops partly through changes in the GABA-A receptor itself. Receptor subunits get rearranged or reduced in number, and excitatory glutamate systems ramp up to compensate for the constant damping effect of the drug.6PubMed Central. Benzodiazepine Dependence: Clinical and Molecular Aspects, Preventive Strategies and Therapeutic Approaches When the benzodiazepine is suddenly removed, the brain’s “slow down” system is weakened while the “speed up” system is running hot. The result can be severe: anxiety, insomnia, tremors, and in serious cases, seizures. Abrupt discontinuation of high-dose benzodiazepines has caused convulsive status epilepticus, a life-threatening condition of continuous seizures, even in people with no prior seizure history.7PubMed. Convulsive status epilepticus following abrupt high-dose benzodiazepine discontinuation In rare and extreme cases, benzodiazepine withdrawal has been fatal. One documented case involved a patient who developed high blood pressure, elevated temperature, bizarre behavior, seizure-like activity, and died about 15 hours after hospital admission.8The American Journal of Forensic Medicine and Pathology. A Fatal Case of Benzodiazepine Withdrawal
Opioid withdrawal, while intensely miserable, follows a different pattern. Physical dependence on opioids means the body’s own pain-modulation and stress-response systems have recalibrated around the drug’s presence. When the opioid is removed, withdrawal symptoms include sweating, nausea, vomiting, diarrhea, muscle aches, and severe anxiety.9PubMed. Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: Current understanding and approaches to management These symptoms, while agonizing, are rarely directly fatal in otherwise healthy adults. The lethality of opioid withdrawal comes more from dehydration, aspiration, or relapse overdose than from the withdrawal process itself. This is a crucial clinical distinction: benzodiazepine withdrawal can kill through seizures; opioid withdrawal is more likely to kill indirectly.
For both drugs, the medical consensus is clear that stopping abruptly after prolonged use is risky, and a supervised tapering schedule is the standard of care. But the specific taper protocols, the medications used to help, and the medical monitoring required are tailored to the drug class involved.
Different Antidotes for Different Overdoses
Perhaps the most concrete proof that these are different drug classes is that they have entirely different antidotes. Naloxone (Narcan) reverses opioid overdoses by knocking opioid molecules off the mu receptor. Flumazenil reverses benzodiazepine overdoses by knocking benzodiazepine molecules off the GABA-A receptor. Each antidote is highly specific to its target drug class and does nothing for the other.10PubMed Central. Flumazenil, naloxone and the ‘coma cocktail’
This has real consequences. If someone has overdosed and a bystander administers naloxone, it will help with the opioid component but will not touch any benzodiazepine effects. In mixed overdoses involving both drug types, naloxone alone may not be enough. Flumazenil, meanwhile, is used much more cautiously in clinical settings because reversing benzodiazepines too quickly in a dependent person can trigger the very seizures that make benzodiazepine withdrawal dangerous. Emergency physicians tend to reach for naloxone far more freely than flumazenil for this reason.
If you carry naloxone or know someone who does, it is worth understanding that it is an opioid-specific tool. It will not reverse sedation caused by benzodiazepines, alcohol, or other non-opioid depressants. In a situation where you are unsure what someone has taken, administering naloxone is still recommended because it is safe even if no opioids are involved, but you should not assume that a lack of response means the person has not overdosed.
How Both Drugs Interact With the Brain’s Reward System
One area where benzodiazepines and opioids do share some common ground is in how they can both hijack the brain’s reward circuitry, though they do so through different doors. Opioids directly flood the brain’s reward center with dopamine by activating opioid receptors on neurons in that pathway. Research on addiction more broadly has shown that in people who develop substance use disorders, drug-induced dopamine surges become blunted over time, while dopamine responses to drug-associated cues, like seeing paraphernalia or visiting a familiar location, actually grow stronger, fueling craving.11PubMed Central. Addiction: beyond dopamine reward circuitry
Benzodiazepines reach the reward system more indirectly. By acting on specific GABA-A receptor subtypes, they can disinhibit dopamine-producing neurons in the midbrain, essentially releasing the brakes on the reward pathway rather than pressing the gas pedal directly.12PubMed Central. Hooked on benzodiazepines: GABAA receptor subtypes and addiction The end result, increased dopamine in the reward circuit, overlaps, but the route is different. This distinction matters because it helps explain why benzodiazepine dependence tends to develop more gradually and why the subjective “high” from benzodiazepines is typically less intense than from opioids, even though both can lead to compulsive use.
Prescribing Trends and Shifting Alternatives
The dangers of combining these drugs have reshaped how doctors prescribe both classes. Beyond the FDA’s boxed warning, there has been a broader shift away from both opioids and benzodiazepines toward alternative medications. Among Medicare beneficiaries between 2013 and 2018, opioid and benzodiazepine prescribing decreased while gabapentinoid prescriptions rose by about 36% and antidepressant prescriptions (SSRIs and SNRIs) rose by about 10%.13BMJ. Trends in prescribing pattern of opioid and benzodiazepine substitutes among Medicare part D beneficiaries from 2013 to 2018: a retrospective study
This shift is not without controversy. Gabapentinoids (gabapentin and pregabalin) were initially considered low-risk alternatives, but growing evidence of their own misuse potential has led several states to reclassify gabapentin as a controlled substance. And for patients with genuine anxiety disorders who were doing well on a benzodiazepine, being forced off the medication by a prescriber responding to regulatory pressure can itself cause harm, including withdrawal and destabilization. The policy landscape is still catching up to the pharmacology.
Benzodiazepines and Older Adults
One population where the benzodiazepine-versus-opioid distinction has particular practical importance is older adults. Benzodiazepines are on the Beers Criteria list of medications considered potentially inappropriate for people over 65, primarily because of fall risk, cognitive impairment, and excessive sedation. A retrospective study found that among older adults who discontinued benzodiazepines, the incidence of falls-related events was lower than among those who continued, though the difference did not reach statistical significance after adjusting for other factors.14PubMed Central. Falls Outcomes in Older Adults Following Benzodiazepine/Z-Drug Discontinuation: A Retrospective Cohort Study in an Academic Health System
Opioids in older adults carry their own distinct risks, including constipation severe enough to require hospitalization, respiratory depression that compounds age-related declines in lung function, and delirium. Both drug classes become riskier with age, but the specific risks are different. A geriatrician assessing fall risk is thinking about benzodiazepines. One managing chronic pain is thinking about opioids. Treating them as interchangeable misses the point of each risk profile.
When Benzodiazepines Are Discovered in an Opioid Context
Street drugs complicate the picture further. Illicitly manufactured pills sold as opioids sometimes contain benzodiazepines instead of or in addition to opioids, either as adulterants or substitutes. Novel “designer” benzodiazepines like flualprazolam and etizolam have appeared in toxicology reports alongside fentanyl. For someone who believes they are taking an opioid, unknowingly consuming a benzodiazepine changes the overdose profile: naloxone will not reverse the benzodiazepine component, the withdrawal timeline if dependence develops will be different, and the seizure risk from abrupt cessation introduces dangers that do not exist with opioids alone.
Drug-checking services and fentanyl test strips can identify some of these adulterants, but many novel benzodiazepines are not detected by standard immunoassay drug tests. If you or someone you know uses substances obtained outside the medical system, knowing that benzodiazepines and opioids are different drugs with different reversal agents and different withdrawal dangers is not academic trivia. It is information that could change what emergency interventions work and what medical help is needed.
A Brief Note on History
Opioids have been used for thousands of years, derived originally from the opium poppy. Benzodiazepines are a mid-twentieth-century invention. The first benzodiazepine, chlordiazepoxide, was identified in 1955 by chemist Leo Sternbach and marketed as Librium by 1960. Diazepam (Valium) followed in 1963 and became one of the most prescribed drugs in the world by the 1970s.15PubMed Central. The history of benzodiazepines Benzodiazepines were developed specifically to replace barbiturates, which were effective sedatives but had a terrifyingly narrow margin between a therapeutic dose and a lethal one. Benzodiazepines were marketed as safer alternatives, and in terms of overdose from the drug alone, they generally are. The irony is that their safety profile relative to barbiturates may have contributed to overprescribing, which eventually revealed their own serious dependence risks.
Opioids, by contrast, have a history rooted in pain relief and surgical anesthesia. The development of synthetic opioids in the twentieth century, culminating in fentanyl and its analogs, dramatically increased potency and overdose risk. The two drug classes evolved in parallel but for different clinical needs, and their current entanglement in the overdose crisis reflects prescribing patterns and illicit market dynamics, not any inherent pharmacological kinship.